Gary C. Doolittle, MD
Interim Division Director, Division of Medical Oncology, The University of Kansas Cancer Center
The Capitol Federal Masonic Professor of The University of Kansas Cancer Center
Medical Director, Midwest Cancer Alliance & Center for Telemedicine & Telehealth
Assistant Dean of Foundational Sciences, The University of Kansas School of Medicine
Vice Chair, Education, The University of Kansas School of Medicine
Professor, Hematology/Oncology, The University of Kansas School of Medicine
Dr. Doolittle specializes in melanoma and sarcoma malignancies, oncology and second opinions in cancer. His clinical interests and research focus include clinical trials for the treatment of melanoma and the use of telemedicine technology in the care of the cancer patient. Most recently he has launched a study using telemedicine technology for innovative cancer clinical trials.
Dr. Doolittle joined the faculty of the University of Kansas Medical Center in 1991. He was named the Medical Director for the Center for Telemedicine and Telehealth in 2000, Medical Director of the Midwest Cancer Alliance in 2007 and served as Medical Director for Outpatient Services at The University of Kansas Cancer Center from 2009-2012. Dr. Doolittle also currently serves as the Phase I Curriculum Director for the School of Medicine, Chair of the Kansas Cancer Partnership and has an active outpatient oncology clinic.
As medical director of the Midwest Cancer Alliance, the outreach arm of The University of Kansas Cancer Center, Dr. Doolittle leads the effort to enhance cancer care by collaborating with health professionals throughout Kansas and Western Missouri. Under his direction, the MCA provides professional education, community outreach and access to cutting-edge clinical trials and the latest advancements in cancer care to people in their own communities, bringing more options close to home.
Dr. Doolittle has been active in the telemedicine program at the University of Kansas Medical Center for nearly two decades. As medical director for the Center for Telemedicine and Telehealth, Dr. Doolittle consults for one of the most active telemedicine programs in the United States and has been involved in the establishment of telemedicine clinics for several disciplines. Dr. Doolittle has conducted over 2,500 telemedical visits evaluating and managing patients with a wide variety of hematologic and oncologic disorders. He has been instrumental in expanding the Kansas telemedicine project through the development and establishment of additional services including patient education, support groups and innovative programs such as TeleKidcare®, KUMC’s school-based telemedicine program. Dr. Doolittle has authored numerous publications concerning telemedicine delivery, cost-tracking, and patient satisfaction. In addition to the publications, he has delivered more than 60 presentations at national and international conferences on the topics of telemedicine, palliative care, oncology disorders, cost-tracking and patient satisfaction.
Dr. Doolittle is a native of Kansas and received his undergraduate degree from Pittsburg State University in 1980 and his Medical Degree from the University of Kansas School of Medicine in 1984. He completed his residency in Internal Medicine and fellowship in Hematology/Oncology at the University of Kansas Medical Center in 1987 and 1991 respectively. He is an active member of the American College of Physicians, the American Society of Clinical Oncology (ASCO), the American Society of Hematology (ASH) and the American Telemedicine Association (ATA).